For example, the intervention of KEAP1 inhibitors, such as natural coumarins, promotes Nrf2 activation, which reduces oxidative stress and inflammation in IBD by inhibiting NF-κB and enhancing antioxidant responses, as documented (261). The gene discussed is NFE2L2; the disease is irritable bowel syndrome.